Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

PRP helps with skin, hair, and wound treatments but needs more research for standard use.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

The herbal hair oil made from various plants might be a good alternative to synthetic hair loss treatments.

Omics techniques are needed to understand the scalp microbiome's role in alopecia areata for new treatments.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Mesenchymal stem cells, especially injected into the skin, heal wounds faster and better than chitosan gel or other treatments.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

Eat antioxidant-rich foods, reduce fast food, and explore various treatments for vitiligo.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

Genetically-altered adult stem cells can help in wound healing and are becoming crucial in regenerative medicine and drug design.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.